Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) β1 in cells with nonfunctional TGF-β receptor type III

被引:0
|
作者
Deng, XB [1 ]
Bellis, S [1 ]
Yan, ZF [1 ]
Friedman, E [1 ]
机构
[1] SUNY Hlth Sci Ctr, Dept Pathol, Syracuse, NY 13210 USA
来源
CELL GROWTH & DIFFERENTIATION | 1999年 / 10卷 / 01期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The two major intestinal epithelial cell lineages are columnar fluid-absorbing cells and mucin-producing goblet cells. High levels of transforming growth factor (TGF) beta 1 are found surrounding postmitotic cells in the colonic crypt, suggesting that TGF-beta 1 mediates the maturation and growth inhibition of both epithelial cell types. However, we now show that the injection of recombinant TGF-beta 1 into mice leads to an enrichment of goblet cells, indicating that these normal epithelial cells are resistant to TGF-beta 1, In support of this interpretation, each of two independently isolated cell lines modeling normal colon goblet cells was also growth resistant to exogenous TGF-beta 1 but made levels of TGF-beta receptor (T beta R) I, T beta RII, and T beta III mRNA and protein equal to those made by two TGF-beta 1-sensitive cell lines. No mutations were found in the alk5 or alk2 forms of T beta RI or in T beta RII; these receptors were found on the cell surface, although they could not bind I-125-labeled TGF-beta 1. T beta RIII binds TGF-beta 1, concentrates it, and presents it to T beta RII, The major T beta RIII form, betaglycan, did not undergo normal posttranslational modification in either of the goblet cell lines and could not bind I-125-labeled TGF-beta 1; thus, it was nonfunctional, TGF-beta resistance was overcome by raising TGF-beta 1 levels 100-fold, at which point T beta RII could bind TGF-beta 1, Signaling initiated by these higher TGF-beta 1 levels was blocked by the expression of dominant negative T beta RII, demonstrating that T beta RII and T beta RI were functional. Cells resistant to exogenous TGF-beta 1 maintained functional cell surface T beta RI and T beta RII to mediate responses to autocrine TGF-beta 1, which controlled the maturation of the adhesion protein integrin beta(1). Expression of dominant negative T beta RII in goblet cells greatly inhibited the conversion of the beta(1) integrin from its precursor to its mature form. Thus, in normal intestinal epithelial goblet cells, T beta RI and T beta RII can respond to autocrine but not exogenous TGF-beta without the participation of T beta RIII, Absorptive epithelial cells are growth inhibited by TGF-beta 1 both in vivo and in vitro; therefore, the loss of functional T beta RIIIs on goblet cells allows differential regulation of the two major intestinal epithelial cell types.
引用
下载
收藏
页码:11 / 18
页数:8
相关论文
共 50 条
  • [41] Alterations of transforming growth factor β1 (TGF-β1) and TGFβ receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines
    Wikström, P
    Lindh, G
    Bergh, A
    Damber, JE
    UROLOGICAL RESEARCH, 1999, 27 (03): : 185 - 193
  • [42] Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy -: Amelioration by soluble TGF-β type II receptor
    Russo, Leileata M.
    del Re, Elisabetta
    Brown, Dennis
    Lin, Herbert Y.
    DIABETES, 2007, 56 (02) : 380 - 388
  • [43] Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulation
    Finger, Elizabeth C.
    Lee, Nam Y.
    You, Hye-jin
    Blobe, Gerard C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (50) : 34808 - 34818
  • [44] Sorafenib supresses TGF-β responsiveness by promoting TGF-β type II receptor degradation.
    Wang, Shi-Weigh
    FASEB JOURNAL, 2018, 32 (01):
  • [45] Paneth cell regeneration requires transforming growth factor (TGF)-aprecursor and TGF-β1.
    Seno, H
    Sawada, M
    Fukuzawa, H
    Morita, Y
    Takaishi, S
    Hiai, H
    Chiba, T
    GASTROENTEROLOGY, 1999, 116 (04) : A644 - A644
  • [46] Increased release of transforming growth factor (TGF)-β1, TGF-β2, and chemoattractant mediators in pneumonia
    Bühling, F
    Thölert, G
    Kaiser, D
    Hoffmann, B
    Reinhold, D
    Ansorge, S
    Welte, T
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (03): : 271 - 278
  • [47] Matrix metalloproteinase 2 activation of transforming growth factor-β1 (TGF-β1) and TGF-β1-type II receptor signaling within the aged arterial wall
    Wang, Mingyi
    Zhao, Di
    Spinetti, Gaia
    Zhang, Jing
    Jiang, Li-Qun
    Pintus, Gianfranco
    Monticone, Robert
    Lakatta, Edward G.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) : 1503 - 1509
  • [48] Latent transforming growth factor-β (TGF-β) binding proteins:: Orchestrators of TGF-β availability
    Rifkin, DB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) : 7409 - 7412
  • [49] Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-β1, and TGF-β type II receptor interact to inhibit the growth of pituitary lactotropes
    Sarkar, DK
    Chaturvedi, K
    Oomizu, S
    Boyadjieva, NI
    Chen, CP
    ENDOCRINOLOGY, 2005, 146 (10) : 4179 - 4188
  • [50] Global gene expression analysis demonstrates that transforming growth factor β1 (TGF-β1) signals exclusively through receptor complexes involving TGF-β receptor I and identifies numerous targets of TGF-β signaling
    Karlsson, G
    Liu, YC
    Goumans, MJ
    Larsson, J
    Lee, JS
    Thorgeirsson, SS
    Ringnér, M
    Karlsson, S
    BLOOD, 2004, 104 (11) : 598A - 598A